383 related articles for article (PubMed ID: 26967236)
1. [The SPRINT Research. A Randomized Trial of Intensive versus Standard Blood-Pressure Control].
Widimský J
Vnitr Lek; 2016 Jan; 62(1):44-7. PubMed ID: 26967236
[TBL] [Abstract][Full Text] [Related]
2. Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial.
Williamson JD; Supiano MA; Applegate WB; Berlowitz DR; Campbell RC; Chertow GM; Fine LJ; Haley WE; Hawfield AT; Ix JH; Kitzman DW; Kostis JB; Krousel-Wood MA; Launer LJ; Oparil S; Rodriguez CJ; Roumie CL; Shorr RI; Sink KM; Wadley VG; Whelton PK; Whittle J; Woolard NF; Wright JT; Pajewski NM;
JAMA; 2016 Jun; 315(24):2673-82. PubMed ID: 27195814
[TBL] [Abstract][Full Text] [Related]
3. A Randomized Trial of Intensive versus Standard Blood-Pressure Control.
; Wright JT; Williamson JD; Whelton PK; Snyder JK; Sink KM; Rocco MV; Reboussin DM; Rahman M; Oparil S; Lewis CE; Kimmel PL; Johnson KC; Goff DC; Fine LJ; Cutler JA; Cushman WC; Cheung AK; Ambrosius WT
N Engl J Med; 2015 Nov; 373(22):2103-16. PubMed ID: 26551272
[TBL] [Abstract][Full Text] [Related]
4. Effects of intensive blood-pressure control in type 2 diabetes mellitus.
; Cushman WC; Evans GW; Byington RP; Goff DC; Grimm RH; Cutler JA; Simons-Morton DG; Basile JN; Corson MA; Probstfield JL; Katz L; Peterson KA; Friedewald WT; Buse JB; Bigger JT; Gerstein HC; Ismail-Beigi F
N Engl J Med; 2010 Apr; 362(17):1575-85. PubMed ID: 20228401
[TBL] [Abstract][Full Text] [Related]
5. Final Report of a Trial of Intensive versus Standard Blood-Pressure Control.
; Lewis CE; Fine LJ; Beddhu S; Cheung AK; Cushman WC; Cutler JA; Evans GW; Johnson KC; Kitzman DW; Oparil S; Rahman M; Reboussin DM; Rocco MV; Sink KM; Snyder JK; Whelton PK; Williamson JD; Wright JT; Ambrosius WT
N Engl J Med; 2021 May; 384(20):1921-1930. PubMed ID: 34010531
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Optimal Diastolic Blood Pressure Range Among Adults With Treated Systolic Blood Pressure Less Than 130 mm Hg.
Li J; Somers VK; Gao X; Chen Z; Ju J; Lin Q; Mohamed EA; Karim S; Xu H; Zhang L
JAMA Netw Open; 2021 Feb; 4(2):e2037554. PubMed ID: 33595663
[TBL] [Abstract][Full Text] [Related]
7. Assessment of Risk of Harm Associated With Intensive Blood Pressure Management Among Patients With Hypertension Who Smoke: A Secondary Analysis of the Systolic Blood Pressure Intervention Trial.
Scarpa J; Bruzelius E; Doupe P; Le M; Faghmous J; Baum A
JAMA Netw Open; 2019 Mar; 2(3):e190005. PubMed ID: 30848803
[TBL] [Abstract][Full Text] [Related]
8. Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) Intensive Blood Pressure Regimen in the United States: Projections From NHANES (National Health and Nutrition Examination Survey).
Bress AP; Kramer H; Khatib R; Beddhu S; Cheung AK; Hess R; Bansal VK; Cao G; Yee J; Moran AE; Durazo-Arvizu R; Muntner P; Cooper RS
Circulation; 2017 Apr; 135(17):1617-1628. PubMed ID: 28193605
[TBL] [Abstract][Full Text] [Related]
9. Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension.
Zhang W; Zhang S; Deng Y; Wu S; Ren J; Sun G; Yang J; Jiang Y; Xu X; Wang TD; Chen Y; Li Y; Yao L; Li D; Wang L; Shen X; Yin X; Liu W; Zhou X; Zhu B; Guo Z; Liu H; Chen X; Feng Y; Tian G; Gao X; Kario K; Cai J;
N Engl J Med; 2021 Sep; 385(14):1268-1279. PubMed ID: 34491661
[TBL] [Abstract][Full Text] [Related]
10. Diastolic Hypotension May Attenuate Benefits from Intensive Systolic Targets: Secondary Analysis of a Randomized Controlled Trial.
Lee TC; Cavalcanti RB; McDonald EG; Pilote L; Brophy JM
Am J Med; 2018 Oct; 131(10):1228-1233.e1. PubMed ID: 29906425
[TBL] [Abstract][Full Text] [Related]
11. Benefit and harm of intensive blood pressure treatment: Derivation and validation of risk models using data from the SPRINT and ACCORD trials.
Basu S; Sussman JB; Rigdon J; Steimle L; Denton BT; Hayward RA
PLoS Med; 2017 Oct; 14(10):e1002410. PubMed ID: 29040268
[TBL] [Abstract][Full Text] [Related]
12. Gender, blood pressure, and cardiovascular and renal outcomes in adults with hypertension from the Systolic Blood Pressure Intervention Trial.
Foy CG; Lovato LC; Vitolins MZ; Bates JT; Campbell R; Cushman WC; Glasser SP; Gillespie A; Kostis WJ; Krousel-Wood M; Muhlestein JB; Oparil S; Osei K; Pisoni R; Segal MS; Wiggers A; Johnson KC;
J Hypertens; 2018 Apr; 36(4):904-915. PubMed ID: 29493562
[TBL] [Abstract][Full Text] [Related]
13. Influence of baseline systolic blood pressure on the relationship between intensive blood pressure control and cardiovascular outcomes in the Systolic Blood Pressure Intervention Trial (SPRINT).
Sun X; Guo Y; Nie Z; Cheng J; Zhou H; Zhong X; Zhang S; Du Z; Zhuang X; Liao X
Clin Res Cardiol; 2019 Mar; 108(3):273-281. PubMed ID: 30167807
[TBL] [Abstract][Full Text] [Related]
14. Systolic blood pressure and cardiovascular outcomes during treatment of hypertension.
Weber MA; Bakris GL; Hester A; Weir MR; Hua TA; Zappe D; Dahlof B; Velazquez EJ; Pitt B; Jamerson K
Am J Med; 2013 Jun; 126(6):501-8. PubMed ID: 23541376
[TBL] [Abstract][Full Text] [Related]
15. Effect of Lowering Diastolic Pressure in Patients With and Without Cardiovascular Disease: Analysis of the SPRINT (Systolic Blood Pressure Intervention Trial).
Khan NA; Rabkin SW; Zhao Y; McAlister FA; Park JE; Guan M; Chan S; Humphries KH
Hypertension; 2018 May; 71(5):840-847. PubMed ID: 29581214
[TBL] [Abstract][Full Text] [Related]
16. Effect of intensive blood pressure lowering on cardiovascular outcomes based on cardiovascular risk: A secondary analysis of the SPRINT trial.
Attar A; Sayadi M; Jannati M
Eur J Prev Cardiol; 2019 Feb; 26(3):238-245. PubMed ID: 30256671
[TBL] [Abstract][Full Text] [Related]
17. [The SPRINT study - the outcomes of the most important study over the recent period focused on hypertension].
Souček M
Vnitr Lek; 2016; 62(11):933-937. PubMed ID: 28128583
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of blood pressure-lowering treatment by the levels of baseline Framingham risk score: A post hoc analysis of the Systolic Blood Pressure Intervention Trial (SPRINT).
Zhang L; Sun X; Liao L; Zhang S; Zhou H; Zhong X; Zhuang X; Liao X
J Clin Hypertens (Greenwich); 2019 Dec; 21(12):1813-1820. PubMed ID: 31670874
[TBL] [Abstract][Full Text] [Related]
19. Optimal Systolic Blood Pressure Target After SPRINT: Insights from a Network Meta-Analysis of Randomized Trials.
Bangalore S; Toklu B; Gianos E; Schwartzbard A; Weintraub H; Ogedegbe G; Messerli FH
Am J Med; 2017 Jun; 130(6):707-719.e8. PubMed ID: 28109971
[TBL] [Abstract][Full Text] [Related]
20. Intensive Versus Standard Blood Pressure Control in SPRINT-Eligible Participants of ACCORD-BP.
Buckley LF; Dixon DL; Wohlford GF; Wijesinghe DS; Baker WL; Van Tassell BW
Diabetes Care; 2017 Dec; 40(12):1733-1738. PubMed ID: 28947569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
